Therapeutic Solutions International Inc (OTCMKTS:TSOI) Comes Crashing Down
Therapeutic Solutions International Inc (OTCMKTS:TSOI) isn’t the sort of company to confine itself to a one-sided business plan. A couple of years ago, it generated its revenues through the sale of plastic devices that supposedly reduced migraine-type headaches. The license agreement on the product expired, however, and the people behind the company were forced to seek other ways of generating sales.
At the end of 2014, TSOI signed another agreement and started selling several brands of dietary supplements. Last week, they told us that ProJuvenol, one of these supplements, could increase the efficacy of the immuno-oncology drugs that are currently on the market. In fact, they are so confident in its ability to battle cancer, that they filed for patent protection.
Investors thought that this is a major step in the right direction for the company. Just minutes after TSOI announced the patent application, Thursday’s session began and during it, traders pushed the ticker from less than $0.003 per share all the way to a little over a penny. TSOI even registered a 52-week high of more than $0.02, and, considering the relatively low price, the dollar volume was quite impressive as well. People around the discussion boards were extremely happy about the news and they organized a competition of sorts during which they tried to find out who can put the highest price target on what was an extremely illiquid ticker not that long ago.
Some of the predictions sounded outlandish at best, and, if Friday’s session is anything to go by, they appear to be downright impossible to reach. The ticker finished last week’s trading with a daily loss of nearly 46% and a price of $0.006 per share.
There are still people around the message boards who reckon that losing 46% of the market cap in a matter of mere hours is called “a nice correction”. The more sober investors, however, now view TSOI as a one-day, a-pop-and-a-drop affair. But is this really that much of a shock?
The truth is, buying and holding TSOI might not be the safest thing to do. We mentioned last week that TSOI hasn’t really been the most actively traded penny stock out there and even the optimistic press releases that the company issued over the last few months weren’t enough to solve the liquidity problems.
We all know that holding shares in a penny stock company and being unable to sell them is a headache. The only thing worse than this is holding shares in a delinquent penny stock company and being unable to sell them. Sadly, TSOI hasn’t filed anything since the report for the third quarter of 2013 and while the management team seem more than happy to update their shareholders on patent applications and other interesting things around the company, they don’t seem too keen on telling us when they expect to present investors with up-to-date financials.
And, when you’re contemplating putting your hard-earned money on the line, the latter seems to be a bit more important.
